Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer
- 1 October 1993
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 106 (4), 703-708
- https://doi.org/10.1016/s0022-5223(19)33714-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Postoperative adjuvant treatments for non-small cell lung cancers: a consensus reportLung Cancer, 1991
- Postoperative adjuvant chemotherapy in non‐small cell lung cancer: Prognostic value of DNA ploidy and postrecurrent survivalJournal of Surgical Oncology, 1991
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986
- Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.Journal of Clinical Oncology, 1986
- A New International Staging System for Lung CancerChest, 1986
- Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lungCancer, 1982
- Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage SchedulesAnnals of Internal Medicine, 1981
- Reporting results of cancer treatmentCancer, 1981
- Assessment of the Role of Surgery for Control of Lung CancerThe Annals of Thoracic Surgery, 1977